Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Metsera Inc Developer of medicines for obesity and metabolic diseases. |
United States | 13 Nov 2024 | Series B Follow-on investment. Round participant. Active |